SAN JOSE, Calif., April 11, 2018 -- The latest market report published by Credence Research, Inc. “Urology Endoscopes Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global urology endoscopes market was valued at US$ 871.0 Mn in 2017, and is expected to reach US$ 1,848.4 Mn by 2026 expanding at a CAGR of 8.68% from 2018 to 2026.
Market Insights:
Urology endoscope technology is undergoing tremendous upgradation wherein miniaturization of the optical technology will constitute the future of surgical procedures. Tiny nanobiotics and nano-bots shall be released in the bloodstream to target the malignancies in the urology region. Ureteroscopes have been coupled with metal oxide conductor technology which has improved vision and drastically reduced surgical timings in the management of renal calculi.
Resectoscopes are widely used by urologist for the diagnosis of urethral endothelium. Saline resectoscopes are useful in the treatment of voids in urinary bladder and preventing TURP syndrome. Cystoscopes are available in different sizes with specialized ergonomic designs for the diagnosis and treatment of hematuria and interstitial cystitis. Ureteroscopes are finding huge therapeutic application in the diagnosis and treatment of urolithiasis.
Urethral and urinary bladder complications are more frequent owing to the rising incidence of urinary tract infection and unsafe sex. Mucosal wall scarring results in hematuria and painful micturition. Urolithiasis is occurring at a rapid pace due to rising prevalence of hypercalciuria and uric acid enriched dietary intake.
North America is the leader in the urology endoscopes market owing to its evolved healthcare infrastructure performing accurate diagnosis and increasing number of patients suffering with lower urinary tract infection. Technical advancement in the lenses and camera utilized in urology endoscopes has led to the emergence of domestic players creating competitive environment for key players in Asia Pacific region. Supportive regulatory environment for urology endoscopes contributes to the growth of Asia Pacific market.
The leaders in the global urology endoscopes market are Karl Storz, Boston Scientific Corporation, Cook Medical, Inc., Covidien Plc, Richard Wolf GmbH, Ethicon Endo-Surgery, Inc., Invendo Medical GmbH, Olympus Corporation, Siemens Healthcare and Stryker Corporation.
Key Market Movements:
- Increasing number of patients suffering with renal complications such as urinary bladder injuries and renal calculi
- Technical advancement in the lenses and camera utilized for visualization and latest ergonomic design drives the demand for new urology endoscopes
- Supportive regulatory environment for urology endoscopes in developing countries contributes to the market growth.
Browse Full Report With TOC, Figures And Tables @ http://www.credenceresearch.com/report/urology-endoscopes-market
Related Reports:
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail: [email protected]
Ph: +1-800-361-8290
Connect With US:
Web: Credence Research
Facebook @ https://www.facebook.com/CredenceResearch
Twitter @ https://twitter.com/CredenceResearc
LinkedIn @ https://us.linkedin.com/company/credenceresearch
G+ @ https://plus.google.com/+Credenceresearch


AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
World game at war: why some European nations have threatened a World Cup boycott
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Same sparkle, different story: how lab-grown diamonds are transforming the market
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 



